[The effect of hormone substitution therapy on body weight].
Giorgia Menozzi
Abstract
Giorgia Menozzi
Abstract
BACKGROUND: The influence of hormone replacement therapy on the body weight has been studied. METHODS: For this purpose, a group of 205 women in spontaneous menopause, were selected at the Menopause Centre in Suzzara: they were given a continuative replacement therapy for a period of 12 months (estradiol 50/60 micrograms and medroxyprogesterone acetate, 5/10 micrograms twelve days a month). RESULTS: After twelve months, 30% of the 200 patients who completed the study, showed a weight increase which was significant only in 20%, with no variation of the Body Mass Index. CONCLUSIONS: From the data obtained, two remarks can be done: the HRT contributes in an insignificant way to the body weight and probably these results must also be ascribed to the choice of neutral progestinics which do not possess androgenical mineralcorticoid effects.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND: The influence of hormone replacement therapy on the body weight has been studied. METHODS: For this purpose, a group of 205 women in spontaneous menopause, were selected at the Menopause Centre in Suzzara: they were given a continuative replacement therapy for a period of 12 months (estradiol 50/60 micrograms and medroxyprogesterone acetate, 5/10 micrograms twelve days a month). RESULTS: After twelve months, 30% of the 200 patients who completed the study, showed a weight increase which was significant only in 20%, with no variation of the Body Mass Index. CONCLUSIONS: From the data obtained, two remarks can be done: the HRT contributes in an insignificant way to the body weight and probably these results must also be ascribed to the choice of neutral progestinics which do not possess androgenical mineralcorticoid effects.
Key concepts: Medicine, Medroxyprogesterone acetate, Hormone replacement therapy (female-to-male), Body mass index, Menopause, Body weight, Hormone therapy, Medroxyprogesterone